Quality survey Health benefits Safety Reading labels Ask the supplier Standards & regulations


Testing news
Ask the expert
Contact us
Privacy policy

Research news

Government Report Concludes That SAM-e Decreases Joint Discomfort
Ridgefield CT, 19 December 2002

A report issued by the U.S. Department of Health and Human Services Agency for Healthcare Research and Quality concludes that SAM-e is effective for joint discomfort.

Entitled "S-Adenosyl-L-Methionine for Treatment of Depression, Osteoarthritis, and Liver Disease," the report conducted a search of the published literature on the use of SAM-e within several areas and, on the basis of that search, evaluated the evidence for the efficacy of SAM-e. Of the studies measured, 10 were included in a meta-analysis of the efficacy of SAM-e to decrease joint discomfort. The data indicated that "SAM-e is more effective than placebo" and that it was shown to be "equivalent to standard therapy," according to the scientific review.

"The results of this compelling report reiterate what many have believed all along—that SAM-e is indeed a promising and natural alternative for joint discomfort associated with everyday activities," said Barbara Levine, a board member of the Pharmaton Institute for Wellness.

Pharmaton Natural Health Products, a leading marketer of natural supplements, offers two products with SAM-e to meet the needs of a growing number of Americans who are looking for ways to help support their joint health.

The Department of Health and Human Services Agency for Healthcare Research and Quality is expected to post the full SAM-e Evidence Report on its website.


Pharmaton Institute for Wellness, manufacturers of two Flexium™ products that contain SAM-e.end-of-story


Health benefits Safety Reading labels Ask the supplier Standards & regulations Contact us

(c) Copyright 1999-2003 Dietary Supplement Quality Initiative. For permission to reprint, please contact our editor.